Corcept Therapeutics Incorporated
CORT
$72.27
-$0.79-1.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 106.11M | 133.66M | 133.99M | 141.21M | 141.82M |
| Total Depreciation and Amortization | 1.87M | 1.89M | 1.62M | 1.34M | 1.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.11M | 15.16M | 13.43M | 10.23M | 5.68M |
| Change in Net Operating Assets | 6.76M | 30.96M | 29.87M | 44.77M | -4.52M |
| Cash from Operations | 162.85M | 181.66M | 178.91M | 197.54M | 144.12M |
| Capital Expenditure | -282.00K | -1.92M | -2.28M | -2.17M | -2.05M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.52M | -39.52M | -169.49M | -175.43M | -94.10M |
| Cash from Investing | 17.24M | -41.44M | -171.76M | -177.60M | -96.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 22.59M | 20.66M | 11.38M | 9.62M | 8.96M |
| Repurchase of Common Stock | -216.30M | -189.05M | -78.99M | -37.97M | -31.98M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -193.71M | -168.39M | -67.61M | -28.35M | -23.02M |
| Foreign Exchange rate Adjustments | 1.47M | 2.33M | 530.00K | 530.00K | 530.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.15M | -25.84M | -59.93M | -7.89M | 25.49M |